Literature DB >> 34217893

Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes.

Rhiannon B Werder1, Joseph E Kaserman2, Michael S Packer3, Jonathan Lindstrom-Vautrin4, Carlos Villacorta-Martin4, Lauren E Young3, Yvonne Aratyn-Schaus3, Francine Gregoire3, Andrew A Wilson5.   

Abstract

Alpha-1 antitrypsin deficiency (AATD) is most commonly caused by the Z mutation, a single-base substitution that leads to AAT protein misfolding and associated liver and lung disease. In this study, we apply adenine base editors to correct the Z mutation in patient induced pluripotent stem cells (iPSCs) and iPSC-derived hepatocytes (iHeps). We demonstrate that correction of the Z mutation in patient iPSCs reduces aberrant AAT accumulation and increases its secretion. Adenine base editing (ABE) of differentiated iHeps decreases ER stress in edited cells, as demonstrated by single-cell RNA sequencing. We find ABE to be highly efficient in iPSCs and do not identify off-target genomic mutations by whole-genome sequencing. These results reveal the feasibility and utility of base editing to correct the Z mutation in AATD patient cells.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adenine base editor; alpha-1 antitrypsin deficiency; base edit; hepatocyte; human induced pluripotent stem cells; iHep; iPSC; single cell RNA sequencing; whole genome sequencing

Mesh:

Substances:

Year:  2021        PMID: 34217893      PMCID: PMC8571173          DOI: 10.1016/j.ymthe.2021.06.021

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   12.910


  47 in total

1.  Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells.

Authors:  Junfeng Ji; Siemon H Ng; Vivek Sharma; Dante Neculai; Samer Hussein; Michelle Sam; Quang Trinh; George M Church; John D McPherson; Andras Nagy; Nizar N Batada
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

2.  Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response.

Authors:  Tunda Hidvegi; Bela Z Schmidt; Pamela Hale; David H Perlmutter
Journal:  J Biol Chem       Date:  2005-09-23       Impact factor: 5.157

3.  Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.

Authors:  M D Wewers; M A Casolaro; S E Sellers; S C Swayze; K M McPhaul; J T Wittes; R G Crystal
Journal:  N Engl J Med       Date:  1987-04-23       Impact factor: 91.245

4.  Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos.

Authors:  Erwei Zuo; Yidi Sun; Wu Wei; Tanglong Yuan; Wenqin Ying; Hao Sun; Liyun Yuan; Lars M Steinmetz; Yixue Li; Hui Yang
Journal:  Science       Date:  2019-02-28       Impact factor: 47.728

5.  Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements.

Authors:  Michael Kosicki; Kärt Tomberg; Allan Bradley
Journal:  Nat Biotechnol       Date:  2018-07-16       Impact factor: 54.908

6.  Engineered CRISPR-Cas9 nuclease with expanded targeting space.

Authors:  Hiroshi Nishimasu; Xi Shi; Soh Ishiguro; Linyi Gao; Seiichi Hirano; Sae Okazaki; Taichi Noda; Omar O Abudayyeh; Jonathan S Gootenberg; Hideto Mori; Seiya Oura; Benjamin Holmes; Mamoru Tanaka; Motoaki Seki; Hisato Hirano; Hiroyuki Aburatani; Ryuichiro Ishitani; Masahito Ikawa; Nozomu Yachie; Feng Zhang; Osamu Nureki
Journal:  Science       Date:  2018-08-30       Impact factor: 47.728

7.  Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells.

Authors:  Waseem Qasim; Hong Zhan; Sujith Samarasinghe; Stuart Adams; Persis Amrolia; Sian Stafford; Katie Butler; Christine Rivat; Gary Wright; Kathy Somana; Sara Ghorashian; Danielle Pinner; Gul Ahsan; Kimberly Gilmour; Giovanna Lucchini; Sarah Inglott; William Mifsud; Robert Chiesa; Karl S Peggs; Lucas Chan; Farzin Farzeneh; Adrian J Thrasher; Ajay Vora; Martin Pule; Paul Veys
Journal:  Sci Transl Med       Date:  2017-01-25       Impact factor: 17.956

8.  5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency.

Authors:  Christian Mueller; Gwladys Gernoux; Alisha M Gruntman; Florie Borel; Emer P Reeves; Roberto Calcedo; Farshid N Rouhani; Anthony Yachnis; Margaret Humphries; Martha Campbell-Thompson; Louis Messina; Jeffrey D Chulay; Bruce Trapnell; James M Wilson; Noel G McElvaney; Terence R Flotte
Journal:  Mol Ther       Date:  2017-04-10       Impact factor: 11.454

9.  In vivo base editing of post-mitotic sensory cells.

Authors:  Wei-Hsi Yeh; Hao Chiang; Holly A Rees; Albert S B Edge; David R Liu
Journal:  Nat Commun       Date:  2018-06-05       Impact factor: 14.919

10.  COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites.

Authors:  Thomas J Cradick; Peng Qiu; Ciaran M Lee; Eli J Fine; Gang Bao
Journal:  Mol Ther Nucleic Acids       Date:  2014-12-02       Impact factor: 10.183

View more
  3 in total

Review 1.  Recent advancements in understanding the genetic involvement of alpha-1 antitrypsin deficiency associated lung disease: a look at future precision medicine approaches.

Authors:  Auyon J Ghosh; Brian D Hobbs
Journal:  Expert Rev Respir Med       Date:  2022-01-13       Impact factor: 3.772

2.  Evaluation of cytosine base editing and adenine base editing as a potential treatment for alpha-1 antitrypsin deficiency.

Authors:  Michael S Packer; Vivek Chowdhary; Genesis Lung; Lo-I Cheng; Yvonne Aratyn-Schaus; Dominique Leboeuf; Sarah Smith; Aalok Shah; Delai Chen; Marina Zieger; Brian J Cafferty; Bo Yan; Giuseppe Ciaramella; Francine M Gregoire; Christian Mueller
Journal:  Mol Ther       Date:  2022-02-02       Impact factor: 12.910

Review 3.  Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.

Authors:  Mahsa Ghasemzad; Mahdieh Hashemi; Zohre Miri Lavasani; Nikoo Hossein-Khannazer; Haleh Bakhshandeh; Roberto Gramignoli; Hani Keshavarz Alikhani; Mustapha Najimi; Saman Nikeghbalian; Massoud Vosough
Journal:  Bioengineering (Basel)       Date:  2022-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.